ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

503.90 +0.30 (+0.06%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	610,220
Open	503.70
Bid (Size)	456.10 (40)
Ask (Size)	503.50 (440)
Prev. Close	503.60
Today's Range	491.97 - 507.93
52wk Range	266.98 - 537.19
Shares Outstanding	44,891,523
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

February 26, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Why United Therapeutics (UTHR) Shares Are Sliding Today

February 26, 2026

Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) fell 7.2% in the afternoon session after the company reported fourth-quarter financial results that missed revenue expectations,...

Via StockStory

Performance

YTD	+1.4%	+1.4%
1 Month	+7.8%	+7.8%
3 Month	+3.7%	+3.7%
6 Month	+65.3%	+65.3%
1 Year	+55.7%	+55.7%

More News

The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough

February 26, 2026

Via Finterra

United Therapeutics Corp. (NASDAQ:UTHR) Reports Record Annual Revenue Despite Q4 Top-Line Miss ↗

February 25, 2026

Via Chartmill

United Therapeutics Corp. (NASDAQ:UTHR) Passes the "Caviar Cruise" Quality Investing Screen ↗

February 12, 2026

Via Chartmill

United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’

February 26, 2026

Via Finterra

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ ↗

February 25, 2026

Via Stocktwits

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

February 25, 2026

Via StockStory

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

February 25, 2026

From United Therapeutics Corporation

Via Business Wire

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

February 23, 2026

Via StockStory

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

February 23, 2026

From United Therapeutics Corporation

Via Business Wire

6 Stock Ideas for the Next 5 Years ↗

February 17, 2026

Via The Motley Fool

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026

February 11, 2026

From United Therapeutics Corporation

Via Business Wire

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

Via StockStory

$100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗

January 29, 2026

Via The Motley Fool

This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗

January 29, 2026

Via The Motley Fool

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

January 27, 2026

Via StockStory

United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure

January 26, 2026

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors

January 22, 2026

From United Therapeutics Corporation

Via Business Wire

3 Market-Beating Stocks to Target This Week

January 15, 2026

Via StockStory

Investment Advisor Doubles Down on Insurance Stock, According to Recent SEC Filing ↗

January 15, 2026

Via The Motley Fool

Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase ↗

January 15, 2026

Via The Motley Fool

2 Cash-Heavy Stocks to Target This Week and 1 We Question

January 11, 2026

Via StockStory

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From United Therapeutics Corporation

Via Business Wire

Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers

December 21, 2025

Via StockStory

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?

Yes, United Therapeutics Corporation - Common Stock is publicly traded.

What exchange does United Therapeutics Corporation - Common Stock trade on?

United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for United Therapeutics Corporation - Common Stock?

The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market

What is the current price of United Therapeutics Corporation - Common Stock?

The current price of United Therapeutics Corporation - Common Stock is 503.90

When was United Therapeutics Corporation - Common Stock last traded?

The last trade of United Therapeutics Corporation - Common Stock was at 02/27/26 04:00 PM ET

What is the market capitalization of United Therapeutics Corporation - Common Stock?

The market capitalization of United Therapeutics Corporation - Common Stock is 22.62B

How many shares of United Therapeutics Corporation - Common Stock are outstanding?

United Therapeutics Corporation - Common Stock has 23B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.